Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-31

Clinical Trial Update: Vitamin D Supplementation in Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update on vitamin D supplementation in patients with diabetic nephropathy and sub-optimal vitamin D status, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D supplementation (Cholecalciferol)

Snippet

Sponsor: University of Alberta | Conditions: Sub-optimal Vitamin D Status, Bone Disease | Phase 2 | Status: COMPLETED